login
login

Europe Daily Bulletin No. 8805

13 October 2004
Contents Publication in full By article 32 / 41
GENERAL NEWS / (eu) eu/drugs

12/10/2004 (Agence Europe) - Further to the withdrawal from the market of the drug Vioxx by Merck Sharp & Dohme on 30 September, the European Medicines Agency decided on 5 October to re-examine the data on cardiovascular safety for all non-steroidal anti-inflammatories in the coxib family, within the next two weeks.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS